ESC 365 - Is sidenafil treatment associated with higher rate of vasoplegic syndrome after heart transplantation?

HFA Premium Access

Is sidenafil treatment associated with higher rate of vasoplegic syndrome after heart transplantation?

Session: Poster Session 2 - Advanced heart failure

Topic: Advance heart failure

Speaker: Mr E. Sole Gonzalez (Barcelona, ES)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

About the speaker

Mr Eduard Sole Gonzalez

Hospital Clinic, University of Barcelona, Barcelona (Spain)

0 follower

7 more presentations in this session

Ways of reducing mortality in waiting list of heart transplant

Speaker: Professor M. Sitnikova (Saint Petersburg, RU)

Influence of cytomegalovirus infection on long-term mortality and cardiac allograft vasculopathy risk after heart transplant

Speaker: Doctor G. Barge-Caballero (A Coruna, ES)

Long term outcome in patients with cardiac resynchronization therapy

Patient selection for heart transplantation: a survival benefit index accounting for both waiting-list and post-transplantation mortality

Speaker: Doctor L. Nguyen (Paris, FR)

Identification and treatment of iron deficiency in advanced heart failure patients listed for heart transplantation

Speaker: Doctor A. Soltan (Oxford, GB)

Access the full session

Poster Session 2 - Advanced heart failure

Speakers: Mr E. Sole Gonzalez, Professor M. Sitnikova, Doctor G. Barge-Caballero, Doctor L. Nguyen, Doctor A. Soltan

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources